Close Menu

In separate letters, Intellia Therapeutics and Editas Medicine criticize a recent report in Nature Methods that found that CRISPR/Cas9-based gene editing led to unexpected changes, Technology Review

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Times of India reports on a pilot study that used genomic testing to determine whether patients had drug-resistant tuberculosis.

New guidelines say that more women may benefit from genetic testing for hereditary breast or ovarian cancer, according to the Los Angeles Times.

In Cell this week: small proteins identified among human microbiome, role for tumor microbes in pancreatic cancer survival, and more.

Holden Thorp is to be the new editor-in-chief of Science and its related journals.